Additionally, inverse associations were found in those who wee diagnosed with ER+/PR+ malignancy and those who receiving anastrozole as endocrine therapy.
In the study, cancer returned in 16 percent of women taking tamoxifen plus Prozac, Paxil, or Zoloft -- but recurred in only 7.5 percent of women on tamoxifen alone.